Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis

Jeremy Miles(School of the Art Institute of Chicago), Damianos G. Kokkinidis(Memorial Hospital of South Bend), Robert Siegel(School of the Art Institute of Chicago), Balaram Krishna J. Hanumanthu(School of the Art Institute of Chicago), Kavisha Patel(Brigham and Women's Hospital), Michelle Chen(Broad Institute)

Journal of Cardiovascular Medicine

April 13, 2019

10.2459/jcm.0000000000000794

Cited by 34

Related Papers

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York

|Metabolism|2020|901

Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

|JAMA Cardiology|2019|418

Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice

|Blood|2018|126

Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer’s Disease: a Systematic Review and Meta-Analysis

|Journal of General Internal Medicine|2021|125

Management of venous thromboembolism in pregnancy

|Thrombosis Research|2022|91